Short answer · Medically reviewed summary · Last updated: 2026-04-06
Myasthenia Gravis is primarily an autoimmune disorder caused by the body’s immune system mistakenly producing antibodies that disrupt the communication between nerves and muscles. The Mechanism of Myasthenia Gravis At the neuromuscular junction—the site where nerve endings meet muscle fibers—a chemical messenger called acetylcholine must bind to specific receptors on the muscle to trigger contraction. In Myasthenia Gravis, the immune system produces antibodies that either block, alter, or destroy these acetylcholine receptors.
9 people with Myasthenia Gravis have shared their first-person experience on this question at DiseaseMaps.
Myasthenia Gravis is primarily an autoimmune disorder caused by the body’s immune system mistakenly producing antibodies that disrupt the communication between nerves and muscles.
At the neuromuscular junction—the site where nerve endings meet muscle fibers—a chemical messenger called acetylcholine must bind to specific receptors on the muscle to trigger contraction. In Myasthenia Gravis, the immune system produces antibodies that either block, alter, or destroy these acetylcholine receptors. Think of this like a key (acetylcholine) being unable to fit into a lock (the receptor) because the lock has been jammed by gum (the antibodies), preventing the door (the muscle) from opening.
While Myasthenia Gravis is not considered a strictly hereditary disease, genetic factors can predispose individuals to autoimmune conditions. We often see a higher prevalence of human leukocyte antigen (HLA) types, such as HLA-DRB1, which can influence how the immune system recognizes "self" versus "foreign" invaders. Environmental triggers, such as viral or bacterial infections, are also suspected to act as catalysts that "wake up" the immune system inappropriately in genetically susceptible individuals.
The thymus gland plays a central role in the etiology of Myasthenia Gravis. This gland is a key player in the development of the immune system. In many patients, the thymus remains abnormally large or develops growths called thymomas, which may confuse the immune system and cause it to generate the rogue antibodies that characterize the disease. Current research is focused on understanding how thymic abnormalities contribute to the onset of Myasthenia Gravis and whether thymectomy (surgical removal) can effectively reset the immune response.
It is important to distinguish between a cause and a risk factor: the "cause" is the production of these specific antibodies, while "risk factors" are the underlying genetic or environmental variables that increase the likelihood of this process starting. While we have a strong grasp of the autoimmune mechanisms, the exact "trigger" that initiates the process in any one person remains a primary area of ongoing scientific investigation.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.